or Try an Advanced Search...

    Technical Analysis for DMTK - DermTech, Inc.

    Grade Last Price % Change Price Change
    F 0.09 -11.32% -0.01
    DMTK closed down 11.32 percent on Wednesday, June 26, 2024, on 1.72 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical DMTK trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Calm After Storm Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for DMTK ...

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    DMTK Chart by TradingView
    Basic chart:

    Profile

    DermTech, Inc. Description

    DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.

    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Medicine Cancer Melanoma Dermatology Gene Expression Diagnostic Tests Risk Assessment Pathology Biopsy Skin Cancer Assessment Products Melanoma Skin Cancer Pigmented Lesion Cutaneous Conditions Non Melanoma Skin Cancer

    Is DMTK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 20 Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Jun 20 Dermtech files for Chapter 11, lays off 20% of staff
    Jun 18 DermTech files for chapter 11 bankruptcy protection
    Jun 18 DermTech Files for Voluntary Chapter 11 Protection
    May 14 DermTech GAAP EPS of -$0.58, revenue of $3.85M
    May 14 DermTech Reports First-Quarter 2024 Financial Results
    Apr 19 Cancer test maker Dermtech to cut 100 jobs, explore strategic options
    Apr 18 DermTech exploring strategic alternatives, cutting 56% of staff
    Apr 18 DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
    Apr 1 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    See more DMTK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.8939
    52 Week Low 0.0875
    Average Volume 2,109,471
    200-Day Moving Average 1.08
    50-Day Moving Average 0.44
    20-Day Moving Average 0.26
    10-Day Moving Average 0.20
    Average True Range 0.05
    RSI (14) 18.03
    ADX 34.26
    +DI 12.68
    -DI 38.10
    Chandelier Exit (Long, 3 ATRs) 0.27
    Chandelier Exit (Short, 3 ATRs) 0.23
    Upper Bollinger Bands 0.45
    Lower Bollinger Band 0.07
    Percent B (%b) 0.07
    BandWidth 147.19
    MACD Line -0.10
    MACD Signal Line -0.08
    MACD Histogram -0.013
    Fundamentals Value
    Market Cap 3.22 Million
    Num Shares 34.2 Million
    EPS -3.48
    Price-to-Earnings (P/E) Ratio -0.03
    Price-to-Sales 2.98
    Price-to-Book 0.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.11
    Resistance 3 (R3) 0.11 0.11 0.11
    Resistance 2 (R2) 0.11 0.10 0.11 0.11
    Resistance 1 (R1) 0.10 0.10 0.10 0.10 0.11
    Pivot Point 0.09 0.09 0.09 0.09 0.09
    Support 1 (S1) 0.09 0.09 0.09 0.09 0.08
    Support 2 (S2) 0.08 0.09 0.08 0.08
    Support 3 (S3) 0.08 0.08 0.08
    Support 4 (S4) 0.08